Sagimet Biosciences Presents Two Posters at EASL 2026 on Denifanstat/Resmetirom Combination in MASH

Go back to Sagimet Biosciences Presents Two Posters at EASL 2026 on Denifanstat/Resmetirom Combination in MASH
(NASDAQ: SGMT) Delayed: 7.06 --0 (-0%)
Previous Close $7.06    52 Week High
Open $7.06    52 Week Low
Day High $7.06    P/E N/A 
Day Low $7.06    EPS
Volume 3,108